Special Issue "Cardiac Disorders Linked to Chronic Kidney Disease"

A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425).

Deadline for manuscript submissions: closed (30 September 2019) | Viewed by 333

Special Issue Editors

HEMATIM, le Centre Universitaire de Recherche en Santé (CURS), Université de Picardie Jules Verne, Amiens, France
Interests: microRNA; chronic kidney disease; erythriopoiesis; cardiovascular disease; gene regulation; multi-omics; miR-223; biomarker
Special Issues, Collections and Topics in MDPI journals
Inserm U1148 Laboratory for Vascular Translational Science (LVTS), University Paris 13-Sorbonne Paris Cite, UFR Smbh, 74 rue Marcel Cachin, F-93017 Bobigny, France
Interests: chronic kidney disease; non coding RNA; anemia cardiovasculat disease
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The heart and the kidneys interact with each other to preserve organ perfusion and hemodynamic stability through a complex organization. As these two organs are interdependent, acute or chronic dysfunction in one organ induces acute or chronic dysfunction in the other. Patients afflicted with chronic kidney disease (CKD) have a high load of cardiovascular morbidity and mortality, and this is part of the cardiorenal syndrome. Cardiac biomarkers are often deregulated in CKD even when symptoms are not apparent, and careful interpretation of cardiac biomarkers can provide important diagnostic and prognostic information. There is a need for innovative biomarkers to monitor heart and kidney condition in CKD, including in the epigenetics field. It is also important to develop gene network and multi-omics technologies in this field to better detect these biomarkers. These molecules would be helpful to develop targets for new therapeutic approaches and new prospects in early intervention for CKD patients. In this special issue, we will deal with the biological, pathological, and clinical relationship between CVD and CKD and their therapeutic administration, with an emphasis on the gene regulation networks that are deregulated in the cardiorenal syndrome.

Prof. Laurent Metzinger
Dr. Valérie Metzinger-Le Meuth
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • biomarker
  • chronic kidney disease
  • cardiovascular disease
  • cardiorenal syndrome

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop